EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
E Eskilsson, GV Røsland, G Solecki, Q Wang… - Neuro …, 2018 - academic.oup.com
Patients with glioblastoma (GBM) have a universally poor prognosis and are in urgent need
of effective treatment strategies. Recent advances in sequencing techniques unraveled the …
of effective treatment strategies. Recent advances in sequencing techniques unraveled the …
Leptomeningeal metastasis from systemic cancer: review and update on management
N Wang, MS Bertalan, PK Brastianos - Cancer, 2018 - Wiley Online Library
Leptomeningeal metastasis is an uncommon and typically late complication of cancer with a
poor prognosis and limited treatment options. Diagnosis is often challenging, with …
poor prognosis and limited treatment options. Diagnosis is often challenging, with …
Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity
Purpose: Approximately one-third of patients with non–small cell lung cancer (NSCLC)
harboring tumors with EGFR-tyrosine kinase inhibitor (TKI)-sensitizing mutations (EGFRm) …
harboring tumors with EGFR-tyrosine kinase inhibitor (TKI)-sensitizing mutations (EGFRm) …
[HTML][HTML] Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non–small-cell lung cancer
AJ Weickhardt, B Scheier, JM Burke, G Gan… - Journal of Thoracic …, 2012 - Elsevier
Introduction: Many patients with oncogene-driven non–small-cell lung cancer (NSCLC)
treated with tyrosine kinase inhibitors experience limited sites of disease progression. This …
treated with tyrosine kinase inhibitors experience limited sites of disease progression. This …
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
K Natarajan, Y Xie, MR Baer, DD Ross - Biochemical pharmacology, 2012 - Elsevier
Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance
protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter …
protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter …
Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma
Brain metastases (BM) occur frequently in many cancers, particularly non–small cell lung
cancer (NSCLC), breast cancer, and melanoma. The development of BM is associated with …
cancer (NSCLC), breast cancer, and melanoma. The development of BM is associated with …
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Purpose Several cases have been reported in which central nervous system (CNS)
metastases of non-small cell lung cancer (NSCLC) resistant to gefitinib were improved by …
metastases of non-small cell lung cancer (NSCLC) resistant to gefitinib were improved by …
Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
O Bruhn, I Cascorbi - Expert opinion on drug metabolism & …, 2014 - Taylor & Francis
Introduction: Human ATP-binding cassette (ABC) transporters act as translocators of
numerous substrates across extracellular and intracellular membranes, thereby contributing …
numerous substrates across extracellular and intracellular membranes, thereby contributing …
Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma
Despite aggressive treatment with radiation and chemotherapy, recurrence of glioblastoma
multiforme (GBM) is inevitable. The objective of this study was to show that the blood-brain …
multiforme (GBM) is inevitable. The objective of this study was to show that the blood-brain …
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
S Shukla, ZS Chen, SV Ambudkar - Drug resistance updates, 2012 - Elsevier
Tyrosine kinases (TKs) are involved in key signaling events/pathways that regulate cancer
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …